Acta Diabetologica

, Volume 50, Issue 3, pp 383–389

Fasting apolipoprotein B48 is a marker for peripheral arterial disease in type 2 diabetes

  • J. Mancera-Romero
  • M. A. Sánchez-Chaparro
  • J. Rioja
  • M. J. Ariza
  • G. Olivecrona
  • P. González-Santos
  • P. Valdivielso
Original Article

DOI: 10.1007/s00592-012-0434-x

Cite this article as:
Mancera-Romero, J., Sánchez-Chaparro, M.A., Rioja, J. et al. Acta Diabetol (2013) 50: 383. doi:10.1007/s00592-012-0434-x

Abstract

An earlier study showed that fasting and postprandial concentrations of apolipoprotein B48 were raised in patients with type 2 diabetes (DM2) and peripheral arterial disease (PAD) as compared with persons without DM2 or persons with DM2 but not PAD. The aim of this study was to confirm the association of PAD and B48 in a larger group of patients with DM2 and the relation of B48 with the preheparin lipoprotein lipase (LPL) mass. We studied 456 patients with DM2. PAD was defined as an ankle-brachial index (ABI) <0.9. Apolipoprotein B48 was quantified by ELISA. Apo B48 was significantly higher in the group with an ABI <0.9 than the groups with ABI of 0.9–1.3 and >1.3 (10.7 ± 6.28 vs. 9.24 ± 5.5 vs. 9.17 ± 8.8 mg/L, ANOVA test, p < 0.05). B48 was independently associated with an ABI <0.9 (OR 1.053; 95 % CI, 1.013–1.094; p < 0.05), together with smoking and duration of diabetes. The preheparin LPL mass was similar in the patients with and without PAD. In conclusion, we confirmed that fasting B48 is an independent marker of PAD in patients with DM2, unrelated to the preheparin LPL mass, statin therapy or glucose lowering treatment.

Keywords

Apolipoprotein B48Type 2 diabetesPeripheral arterial diseaseAnkle-brachial indexLPL mass

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • J. Mancera-Romero
    • 1
  • M. A. Sánchez-Chaparro
    • 2
    • 3
  • J. Rioja
    • 3
  • M. J. Ariza
    • 3
  • G. Olivecrona
    • 4
  • P. González-Santos
    • 2
    • 3
  • P. Valdivielso
    • 2
    • 3
  1. 1.Centro de Salud “Ciudad Jardín”, Servicio Andaluz de SaludMálagaSpain
  2. 2.Internal Medicine UnitHospital Universitario “Virgen de la Victoria”MálagaSpain
  3. 3.Lipid and Arteriosclerosis Laboratory, Department of Medicine and Dermatology, CIMES Center, School of MedicineUniversity of MálagaMálagaSpain
  4. 4.Department of Medical Biosciences/Physiological ChemistryUmea UniversityUmeåSweden